In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bradley/Osmotics licensing deal to bring Le Pont vitamin C wrinkle patch to mass market.

This article was originally published in The Rose Sheet

Executive Summary

BRADLEY/OSMOTICS TO BRING LE PONT ANTIWRINKLE PATCH TO MASS MARKET under a licensing agreement which gives Fairfield, N.J.-based Bradley Pharmaceuticals exclusive mass market distribution rights to Osmotics' vitamin C dermal patch technology for a five-year period ending July 3, 2002. The vitamin C anti-wrinkle patch will debut in October at mass merchandisers including Wal-Mart, Kmart and Cosmetics Plus, and at chain and independent drug stores under the Le Pont brand name. Bradley's Doak Dermatologics subsidiary will handle the marketing of the Le Pont Beauty Enhancer in the U.S. The product will be sold in the stores' cosmetics sections.



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts